{"id":1068142,"date":"2021-11-07T01:41:24","date_gmt":"2021-11-07T05:41:24","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/wegovy-demonstrated-significant-and-sustained-weight-loss-in-two-year-study-in-adults-with-obesity\/"},"modified":"2024-08-18T11:43:22","modified_gmt":"2024-08-18T15:43:22","slug":"wegovy-demonstrated-significant-and-sustained-weight-loss-in-two-year-study-in-adults-with-obesity","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/wegovy-demonstrated-significant-and-sustained-weight-loss-in-two-year-study-in-adults-with-obesity.php","title":{"rendered":"Wegovy\u2122 demonstrated significant and sustained weight loss in two-year study in adults with obesity"},"content":{"rendered":"<p><![CDATA[Bagsv\u00e6rd, Denmark, 5 November 2021 \u2013 Results from the STEP 5 phase 3b trial, presented today at the ObesityWeek\u00ae 2021 interactive congress, showed that adults treated with Wegovy\u2122 (semaglutide 2.4 mg injection) achieved significant and sustained weight loss over the two-year study period. The STEP 5 trial investigated Wegovy\u2122 vs. placebo, both used with a reduced calorie meal plan and increased physical activity for the treatment of obesity (BMI ?30 kg\/m2) or overweight (BMI ?27 kg\/ m2) in 304 adults with at least one weight-related comorbidity for 104 weeks (two years).1]]><\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2021\/11\/05\/2328560\/0\/en\/Wegovy-demonstrated-significant-and-sustained-weight-loss-in-two-year-study-in-adults-with-obesity.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Wegovy\u2122 demonstrated significant and sustained weight loss in two-year study in adults with obesity\">Wegovy\u2122 demonstrated significant and sustained weight loss in two-year study in adults with obesity<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more: Wegovy\u2122 demonstrated significant and sustained weight loss in two-year study in adults with obesity <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/wegovy-demonstrated-significant-and-sustained-weight-loss-in-two-year-study-in-adults-with-obesity.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068142","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068142"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068142"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068142\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068142"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068142"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068142"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}